Blood test may spot returning colorectal cancer earlier
NCT ID NCT04739072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing if a simple blood test can find tiny bits of tumor DNA left after treatment, which might help doctors know if colorectal cancer will return sooner than current methods. About 1,000 people with colorectal cancer who have finished or are about to start treatment will give blood samples over time. The goal is to see if these DNA signals can predict recurrence and improve follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Banner - MD Anderson Cancer Center
TERMINATEDGilbert, Arizona, 85234, United States
-
Baptist- MD Anderson Cancer Center
TERMINATEDJacksonville, Florida, 32207, United States
-
Baylor Scott & White Research Institute
TERMINATEDTemple, Texas, 76508, United States
-
Cooper Hospital UNIV MED CTR.
TERMINATEDCamden, New Jersey, 08103, United States
-
Houston Methodist Cancer Center
TERMINATEDHouston, Texas, 77030, United States
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
St. Luke's Cancer Institute
TERMINATEDBoise, Idaho, 83712, United States
-
The Queen's Medical Center
TERMINATEDHonolulu, Hawaii, 96813, United States
-
UT Health San Antonio MD Anderson Cancer Center
TERMINATEDSan Antonio, Texas, 78229, United States
-
UT Southwestern/Simmons Cancer Center-Dallas
TERMINATEDDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a new blood test spot colorectal cancer return earlier?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Breath of life: new test could sniff out gut cancers before they spread
- Gut instinct: listening to bowel sounds may reveal hidden clues about surgical recovery
- Experimental drug combo targets Hard-to-Treat GI cancers